<DOC>
	<DOCNO>NCT01425775</DOCNO>
	<brief_summary>Systemic lupus erythematosus ( SLE ) chronic multi-system inflammatory autoimmune disease . Vitamin D potent immunomodulatory property promote potential use treatment autoimmune condition , include SLE . We assess vitamin D status SLE patient determine alteration inflammatory , hemostatic marker well disease activity vitamin D supplementation . 248 SLE patient enrol randomized placebo-controlled study . Patients randomize 2:1 receive either oral cholecalciferol 2000 IU/day placebo 12 month . Outcome measure include assessment alteration level IL-1 , IL-6 , IL-18 , TNF-alpha , Anti-dsDNA , ANA , fibrinogen von Willebrand Factor ( vWF ) 12 month supplementation . Disease activity measure SLEDAI . Vitamin D level measure Liaison immunoassay ; ( normal 30-100ng/ml ) . Serum level 10-30 ng/ml classified vitamin D insufficiency , level &lt; 10 ng/ml vitamin D deficiency.The mean 25 ( OH ) D level baseline 19.8 ng/ml patient compare 28.7 ng/ml control .</brief_summary>
	<brief_title>The Effect Vitamin D Supplementation Disease Activity Markers Systemic Lupus Erythematosus ( SLE )</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Premenopausal woman male body mass index ethnicity Patients : inflammatory disorder , hepatic disease renal disease malignant disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>SLE</keyword>
	<keyword>disease activity marker</keyword>
	<keyword>vitamin D</keyword>
</DOC>